SCHEMBL20272136

SCHEMBL20272136

Cc1cc(Cc2cc(C)c(O)cc2C(C)C)c(C(C)C)cc1C

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE P22303 4/20 0.42
LMNA P02545 2/20 0.40
TRPA1 O75762 2/20 0.38
PTGS1 P23219 1/20 0.38
CACNA1C Q13936 1/20 0.38
CHRM1 P11229 1/20 0.38
SLC6A2 P23975 1/20 0.38
ADRA1A P35348 1/20 0.38
HTR2B P41595 1/20 0.38
CYP1A2 P05177 3/20 0.37
CYP2D6 P10635 2/20 0.37
MAPK1 P28482 2/20 0.37
GPR55 Q9Y2T6 1/20 0.36
CYP3A4 P08684 2/20 0.35
CYP2C19 P33261 2/20 0.35
PKM P14618 2/20 0.35
HSD17B10 Q99714 2/20 0.35
KDM4E B2RXH2 1/20 0.35
ALDH1A1 P00352 1/20 0.35
MAPT P10636 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL68442 0.96 ACHE (0.45) ACHELMNATRPA1PTGS1CACNA1C
Phenol SCHEMBL20258082 0.84 GAA (0.42) ACHELMNATRPA1PTGS1CACNA1C
SCHEMBL11484401 0.82 ACHE (0.44) ACHELMNATRPA1PTGS1CACNA1C
SCHEMBL29060642 0.81 ACHE (0.42) ACHELMNATRPA1PTGS1CACNA1C
SCHEMBL9008334 0.80 LMNA (0.42) ACHELMNATRPA1PTGS1CACNA1C
SCHEMBL28323636 0.79 ACHE (0.41) ACHELMNATRPA1PTGS1CACNA1C
SCHEMBL6229372 0.79 ACHE (0.41) ACHELMNATRPA1PTGS1CACNA1C
SCHEMBL6231907 0.77 XDH (0.44) ACHELMNATRPA1PTGS1CACNA1C
SCHEMBL23766694 0.76 P2RX3 (0.63)
SCHEMBL22380325 0.75 GABRA1 (0.40) LMNATRPA1CHRM1SLC6A2ADRA1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10000433-B1 Bisphenols and high-performance resins from terpenes THE UNITED STATES OF AMERICA AS REPRESENTED BY THE SECRETARY OF THE NAVY (US) 2018-06-19 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10000433-B1 Bisphenols and high-performance resins from terpenes MYB, CETP, TRRAP ACHE 3977/4885LMNA 1369/4885TRPA1 524/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.